These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


278 related items for PubMed ID: 16469671

  • 1. Effects of Helicobacter pylori and nonsteroidal anti-inflammatory drugs on peptic ulcer disease: a systematic review.
    Papatheodoridis GV, Sougioultzis S, Archimandritis AJ.
    Clin Gastroenterol Hepatol; 2006 Feb; 4(2):130-42. PubMed ID: 16469671
    [Abstract] [Full Text] [Related]

  • 2. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis.
    Huang JQ, Sridhar S, Hunt RH.
    Lancet; 2002 Jan 05; 359(9300):14-22. PubMed ID: 11809181
    [Abstract] [Full Text] [Related]

  • 3. [Role of Helicobacter pylori infection and use of NSAIDs in the etiopathogenesis of upper gastrointestinal bleeding].
    Sokić-Milutinović A, Krstić M, Popović D, Mijalković N, Djuranović S, Culafić Dj.
    Acta Chir Iugosl; 2007 Jan 05; 54(1):51-62. PubMed ID: 17633863
    [Abstract] [Full Text] [Related]

  • 4. Risk of ulcer bleeding in patients infected with Helicobacter pylori taking non-steroidal anti-inflammatory drugs.
    Hawkey CJ.
    Gut; 2000 Mar 05; 46(3):310-1. PubMed ID: 10673289
    [Abstract] [Full Text] [Related]

  • 5. [Bleeding peptic ulcer. Prevalence of Helicobacter pylori and use of nonsteroidal anti-inflammatory drugs/acetylsalicylic acid].
    Vestergård A, Bredahl K, de Muckadell OB, Pedersen OB, Hansen JM.
    Ugeskr Laeger; 2009 Jan 19; 171(4):235-9. PubMed ID: 19174039
    [Abstract] [Full Text] [Related]

  • 6. Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease.
    Voutilainen M, Mäntynen T, Färkkilä M, Juhola M, Sipponen P.
    Scand J Gastroenterol; 2001 Aug 19; 36(8):817-21. PubMed ID: 11495076
    [Abstract] [Full Text] [Related]

  • 7. Specifics of Helicobacter pylori infection/NSAID effects in the elderly.
    Davidovic M, Svorcan P, Milanovic P, Antovic A, Milosevic D.
    Rom J Gastroenterol; 2005 Sep 19; 14(3):253-8. PubMed ID: 16200236
    [Abstract] [Full Text] [Related]

  • 8. Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: a case-control study.
    Aalykke C, Lauritsen JM, Hallas J, Reinholdt S, Krogfelt K, Lauritsen K.
    Gastroenterology; 1999 Jun 19; 116(6):1305-9. PubMed ID: 10348813
    [Abstract] [Full Text] [Related]

  • 9. Review article: should NSAID/low-dose aspirin takers be tested routinely for H. pylori infection and treated if positive? Implications for primary risk of ulcer and ulcer relapse after initial healing.
    Hunt RH, Bazzoli F.
    Aliment Pharmacol Ther; 2004 Feb 19; 19 Suppl 1():9-16. PubMed ID: 14725573
    [Abstract] [Full Text] [Related]

  • 10. Role of Helicobacter pylori infection and nonsteroidal anti-inflammatory drug use in bleeding peptic ulcers in Japan.
    Ootani H, Iwakiri R, Shimoda R, Nakahara S, Amemori S, Fujise T, Kikkawa A, Tsunada S, Sakata H, Fujimoto K.
    J Gastroenterol; 2006 Jan 19; 41(1):41-6. PubMed ID: 16501856
    [Abstract] [Full Text] [Related]

  • 11. Eradication of Helicobacter pylori infection reduces the incidence of peptic ulcer disease in patients using nonsteroidal anti-inflammatory drugs: a meta-analysis.
    Tang CL, Ye F, Liu W, Pan XL, Qian J, Zhang GX.
    Helicobacter; 2012 Aug 19; 17(4):286-96. PubMed ID: 22759329
    [Abstract] [Full Text] [Related]

  • 12. Peptic ulcer bleeding: interaction between non-steroidal anti-inflammatory drugs, Helicobacter pylori infection, and the ABO blood group system.
    Kuyvenhoven JP, Veenendaal RA, Vandenbroucke JP.
    Scand J Gastroenterol; 1999 Nov 19; 34(11):1082-6. PubMed ID: 10582757
    [Abstract] [Full Text] [Related]

  • 13. Peptic Ulcer Bleeding Risk. The Role of Helicobacter Pylori Infection in NSAID/Low-Dose Aspirin Users.
    Sostres C, Carrera-Lasfuentes P, Benito R, Roncales P, Arruebo M, Arroyo MT, Bujanda L, García-Rodríguez LA, Lanas A.
    Am J Gastroenterol; 2015 May 19; 110(5):684-9. PubMed ID: 25895518
    [Abstract] [Full Text] [Related]

  • 14. Helicobacter pylori and nonsteroidal anti-inflammatory drugs in perforations and bleeding of peptic ulcers.
    Bobrzyński A, Konturek PC, Konturek SJ, Płonka M, Bielański W, Karcz D.
    Med Sci Monit; 2005 Mar 19; 11(3):CR132-5. PubMed ID: 15735566
    [Abstract] [Full Text] [Related]

  • 15. Interaction between Helicobacter pylori and non-steroidal anti-inflammatory drugs in peptic ulcer bleeding.
    Wu CY, Poon SK, Chen GH, Chang CS, Yeh HZ.
    Scand J Gastroenterol; 1999 Mar 19; 34(3):234-7. PubMed ID: 10232865
    [Abstract] [Full Text] [Related]

  • 16. Role of Helicobacter pylori infection on upper gastrointestinal bleeding in the elderly: a case-control study.
    Pilotto A, Leandro G, Di Mario F, Franceschi M, Bozzola L, Valerio G.
    Dig Dis Sci; 1997 Mar 19; 42(3):586-91. PubMed ID: 9073143
    [Abstract] [Full Text] [Related]

  • 17. Is non-Helicobacter pylori, non-NSAID peptic ulcer a common cause of upper GI bleeding? A prospective study of 977 patients.
    Chan HL, Wu JC, Chan FK, Choi CL, Ching JY, Lee YT, Leung WK, Lau JY, Chung SC, Sung JJ.
    Gastrointest Endosc; 2001 Apr 19; 53(4):438-42. PubMed ID: 11275883
    [Abstract] [Full Text] [Related]

  • 18. Helicobacter pylori increases the risk of peptic ulcer bleeding: a case-control study.
    Labenz J, Peitz U, Köhl H, Kaiser J, Malfertheiner P, Hackelsberger A, Börsch G.
    Ital J Gastroenterol Hepatol; 1999 Mar 19; 31(2):110-5. PubMed ID: 10363194
    [Abstract] [Full Text] [Related]

  • 19. Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding.
    Stack WA, Atherton JC, Hawkey GM, Logan RF, Hawkey CJ.
    Aliment Pharmacol Ther; 2002 Mar 19; 16(3):497-506. PubMed ID: 11876703
    [Abstract] [Full Text] [Related]

  • 20. Contribution of Helicobacter pylori infection to the risk of peptic ulcer bleeding in patients on nonsteroidal anti-inflammatory drugs, antiplatelet agents, anticoagulants, corticosteroids and selective serotonin reuptake inhibitors.
    Venerito M, Schneider C, Costanzo R, Breja R, Röhl FW, Malfertheiner P.
    Aliment Pharmacol Ther; 2018 Jun 19; 47(11):1464-1471. PubMed ID: 29655196
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.